Hib vaccine
Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era
6
Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data
9
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule
10
Knowledge of Interim Recommendations and Use of Hib Vaccine During Vaccine Shortages
9
The immunogenicity and safety of a reduced PRP content DTPw HBV/Hib vaccine when administered according to the accelerated EPI schedule
8
Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria–Tetanus Toxoid–Five-Component Acellular Pertussis (DTaP5), Inactivated Poliovirus (IPV), and Haemophilus influenzae Type b (Hib) Vaccine Compared with a DTaP3-IPV/Hib Vaccine Administered at 3, 5, and 12 Months of Age
7
Blood Cultures in the Evaluation of Children With Cellulitis
6
Occult Bacteremia From a Pediatric Emergency Department: Current Prevalence, Time to Detection, and Outcome
9
Safety and Reactogenicity of a Novel DTPa-HBV-IPV Combined Vaccine Given Along With Commercial Hib Vaccines inComparison With Separate Concomitant Administration ofDTPa, Hib, and OPV Vaccines in Infants
10
Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age
6
Primary and booster vaccination in Latin American children with a DTPw HBV/Hib combination: a randomized controlled trial
9
Up-to-Date Haemophilus influenzae Type b Vaccination Coverage During a Vaccine Shortage
8
Quality of the Haemophilus influenzae Type b (Hib) Antibody Response Induced by Diphtheria-Tetanus-Acellular Pertussis/Hib Combination Vaccines
8
Phase I Clinical Evaluation of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against Haemophilus influenzae Type b in Human Adult Volunteers
5
Increase in Genetic Diversity of Haemophilus influenzae Serotype b (Hib) Strains after Introduction of Hib Vaccination in The Netherlands
9
Factors associated with uptake of Haemophilus influenzae type b vaccination in Shanghai, China
8
Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)
7
Immunogenicity of a Fourth Dose of Haemophilus influenzae Type b (Hib) Conjugate Vaccine and Antibody Persistence in Young Children from the United Kingdom Who Were Primed with Acellular or Whole-Cell Pertussis Component-Containing Hib Combinations in Infancy
6
Molecular Epidemiology of Haemophilus influenzae Type b Causing Vaccine Failures in the United Kingdom
5
Immunologic Response to Haemophilus influenzae Type b (Hib) Conjugate Vaccine and Risk Factors for Carriage among Hib Carriers and Noncarriers in Southwestern Alaska
7